Stifel's Head of Therapeutics Research Paul Matteis shares his take on biotech and discusses companies he covers that have been in the news
Stifel's Head of Therapeutics Research Paul Matteis shares his take on biotech and discusses companies he covers that have been in the news
重點導讀
He discusses Biogen, Alnylam, Xenon, and Compass Pathways
AI 伴隨問答
針對這篇報導有疑問?可直接點選快捷問題或向 AI 追問背景脈絡與技術細節:
Podcast 專家音訊節目
收錄於 888news Podcast 智庫專區,包含精華摘要與上市公司即時行情
正文
He discusses Biogen, Alnylam, Xenon, and Compass Pathways
來源: BiotechTV - News (podcasters.spotify.com)
開啟原文